Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
5.33
-0.37 (-6.49%)
At close: Apr 28, 2026, 4:00 PM EDT
5.25
-0.08 (-1.50%)
After-hours: Apr 28, 2026, 5:25 PM EDT
Cadrenal Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 9.35 | 6.75 | 3.55 | 2.52 |
| Research & Development | 4.1 | 4.21 | 4.08 | 0.43 |
| Operating Expenses | 13.46 | 10.96 | 7.63 | 2.95 |
| Operating Income | -13.46 | -10.96 | -7.63 | -2.95 |
| Interest Expense | - | - | -0.02 | -0.12 |
| Interest & Investment Income | 0.22 | 0.31 | 0.25 | 0 |
| Other Non Operating Income (Expenses) | - | - | -0.22 | -4.26 |
| EBT Excluding Unusual Items | -13.24 | -10.65 | -7.62 | -7.32 |
| Other Unusual Items | - | - | -0.74 | - |
| Pretax Income | -13.24 | -10.65 | -8.36 | -7.32 |
| Net Income | -13.24 | -10.65 | -8.36 | -7.32 |
| Net Income to Common | -13.24 | -10.65 | -8.36 | -7.32 |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 |
| Shares Change (YoY) | 63.48% | 35.59% | 70.99% | - |
| EPS (Basic) | -6.64 | -8.73 | -9.29 | -13.92 |
| EPS (Diluted) | -6.64 | -8.73 | -9.29 | -13.92 |
| Free Cash Flow | -12.61 | -7.36 | -3.53 | -1.32 |
| Free Cash Flow Per Share | -6.32 | -6.04 | -3.93 | -2.50 |
| EBITDA | -13.45 | -10.96 | -7.63 | -2.95 |
| D&A For EBITDA | 0.01 | 0 | 0 | 0 |
| EBIT | -13.46 | -10.96 | -7.63 | -2.95 |
Source: S&P Capital IQ. Standard template.
Financial Sources.